Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8716519 | Journal de Mycologie Médicale / Journal of Medical Mycology | 2018 | 5 Pages |
Abstract
Posaconazole and voriconazole have the same prophylactic effect against IFDs in high-risk neutropenic Chinese patients. However, the safety of posaconazole is superior to that of voriconazole, while in terms of cost-effectiveness, voriconazole has an advantage over posaconazole.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Parasitology
Authors
L. Tang, X.-F. Yang, M. Qiao, L. Zhang, X.-W. Tang, H.-Y. Qiu, D.-P. Wu, A.-N. Sun,